What’s new

• Whole Time Director Mayank Rasiklal Kotadia suffered a brain haemorrhage and is undergoing treatment.
• Audited FY26 financial results will be delayed due to the director's incapacitation.
• The company says it cannot complete processes and obtain approvals within the prescribed timeline.

Why it matters

For a nano-cap, the sudden incapacitation of a key director is a material governance and operational risk. It disrupts compliance and decision-making, raising uncertainty about near-term continuity and investor confidence.

What we’re watching

• When the company submits the delayed FY26 audited results.
• Any updates on the director's health and ability to resume duties.
• Whether other regulatory filings or board decisions are also affected.

The full read

Milestone Furniture, a nano-cap with a market cap of ₹25 cr, has told the exchange that its audited FY26 results will be delayed. The reason: Whole Time Director Mayank Rasiklal Kotadia suffered a brain haemorrhage and is incapacitated. For a company of this size, the sudden unavailability of a key director is a material governance risk. It has halted the internal processes needed to finalise the financials. No timeline for his recovery or for the results has been given. The delay itself may be short, but the underlying key-person risk will hang over the stock until the director returns or the company demonstrates it can function without him.

Primary source: BSE · NSE